All posts
-
Zealand Pharma boss expects 2026 to bring clarity on data potential
One of the most vital point in 2026 will certainly be brand-new information for Zealand’s crown gem, petrelintid, on which the biotech business partnered with Swiss Roche in …
-
Emergency drug returned by Novo Nordisk: Zealand Pharma now wants to sell it on
Novo Nordisk has actually returned the Zegalogue emergency situation pen to Zealand Pharma after holding the civil liberties because 2022.
-
Roche deal bolsters Zealand Pharma’s net profit
Danish Zealand Pharma has actually gotten USD 1.5 bn from Swiss firm Roche with a collaboration bargain concerning the weight-loss prospect petrelintid.
-
Genmab received USD 12.5m in payment from Novo Nordisk in 2025
Genmab’s landmark repayments from its companions completed USD 97m in 2025.
-
Nordea sees strong US demand for Demant product
Demant’s Oticon Zeal hearing aid enjoys strong early demand in the US.
-
Sam Altman would like remind you that humans use a lot of energy, too
“It likewise takes a great deal of power to educate a human.”
-
Wikipedia blacklists Archive.today after alleged DDoS attack
Wikipedia editors have actually chosen to get rid of all web links to Archive.today, an internet archiving solution that they stated has actually been connected to greater than 695…
-
Microsoft’s new gaming CEO vows not to flood the ecosystem with ‘endless AI slop’
Is Microsoft’s pc gaming department increasing down on AI?
-
Google VP warns that two types of AI startups may not survive
As generative AI develops, a Google VP alerts that LLM wrappers and AI collectors encounter placing stress, with reducing margins and restricted distinction endangering their long-…
-
OpenAI debated calling police about suspected Canadian shooter’s chats
Jesse Van Rootselaar’s summaries of weapon physical violence were flagged by devices that keep an eye on ChatGPT for abuse.
